Case Study: Digital Twins for Personalized Rehabilitation at Articulate Labs

Advanced Manufacturing in Action Case Study

Articulate Labs implemented advanced manufacturing technologies during early-stage development of KneeStim™, a wearable medical device designed to deliver movement-synchronous neuromuscular electrical stimulation (NMES). To address the complexities of human gait and enable personalized therapy, Articulate Labs developed an adaptive digital twin using real-time patient movement data and introduced advanced software architectures to improve computational efficiency, processing speed, and device safety. This case study examines the application of three advanced manufacturing techniques:

  • Digital Twins: Creating a personalized representation of each user’s knee and gait cycle using real-time movement data to guide therapeutic stimulation.
  • Dataflow Architecture: Enabling data-driven task execution to reduce CPU processing requirements and support faster device response.
  • Hierarchical State Machine Architecture: Reducing unnecessary processing through structured task management while incorporating safeguards for therapeutic outputs.

Measured Outcomes

In an initial feasibility study involving 20 subjects with evidence of patellofemoral pain syndrome, Articulate Labs evaluated changes in gait in response to KneeStim™. The study reported the following results:

99%

Accuracy in stimulation timing and location

78%

Reduction in variance of tibia angle at heel strike in the leg wearing KneeStim™

46%

Reduction in variance of tibia angle at heel strike in the opposite leg

27%

Reduction in variance of knee range of motion

The variance reductions were observed in the 12-subject cohort using the adaptive algorithm, comparing KneeStim™ operation with the device powered off. Findings are from an initial feasibility study.

More Like This

Simulation-Aided Design via Digital Twin: Nanopath Use Case

Digital Transformation: Laboratory Information Management System (LIMS) for Raw Materials

Patient-Specific Bolus at the Point-Of-Care: RICOH Case Study